Cardiol Therapeutics's total assets for Q4 2025 were C$23.62M, a decrease of -24.79% from the previous quarter. TSE:CRDL total liabilities were C$5.74M for the fiscal quarter, a -20.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.